Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07311733 · ClinicalTrials.gov registry record · NA
Milky Way Sensor: Device Validation for Infiltrated Tissues
A NA study, sponsored by ivWatch.
- Not yet
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT07311733: Clinical Trial NA study, sponsored by ivWatch.
NCT07311733 is a NA study that has not yet begun recruiting, run by ivWatch. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07311733, a NA study, has not yet begun recruiting, sponsored by ivWatch.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
A single arm trial consisting of 28 adult volunteers to assess the safety and efficacy of ivWatch sensors when observing infiltrated tissues at common sites for peripheral IV therapy.
Primary Outcome
The ratio of the number of infiltrated IV sites where the ivWatch Model 400 device issued a red notification to the total number of infiltrated IV sites in the study. All infiltrations were limited to 10 mL of isotonic saline solution.
Interventions
- DEVICE ivWatch Model 400 with Milky Way Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2026-01 |
| Est. Completion | 2026-02 |
| Phase | NA |
What is known before NCT07311733 opens enrollment
NCT07311733 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which ivWatch Model 400 with Milky Way Sensor is the first listed.
NCT07311733 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07311733 about?
NCT07311733 is a clinical study titled "Milky Way Sensor: Device Validation for Infiltrated Tissues". A single arm trial consisting of 28 adult volunteers to assess the safety and efficacy of ivWatch sensors when observing infiltrated tissues at common sites for peripheral IV therapy.
What is the current status of trial NCT07311733?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2026-01. Estimated completion is 2026-02.
What interventions are being tested in trial NCT07311733?
The interventions under investigation include: ivWatch Model 400 with Milky Way Sensor (DEVICE).
Who is sponsoring clinical trial NCT07311733?
This trial is sponsored by ivWatch, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07311733's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia